文献速递主动脉疾病

开窗/分支腔内主动脉修复中桥接支架的结局

Outcomes of bridging stent grafts in fenestrated and branched endovascular aortic repair.
PubMed 文献 · J Vasc Surg · 2020-01-19

该回顾性研究分析了50例复杂主动脉疾病患者接受开窗或分支腔内修复术,共植入145枚VBX桥接支架。技术成功率为98.6%,围术期及动脉瘤相关死亡率为0%,6个月全因死亡率为2%。结论认为所用桥接支架在F/BEVAR中显示初步良好结果,但需进一步评估VBX的耐久性。

要点

  • VBX桥接支架在F/BEVAR中技术成功率达98.6%。
  • 围术期及动脉瘤相关死亡率为0%,6个月全因死亡率为2%。
  • 需进一步评估VBX桥接支架的耐久性。

核心结论

  • 所用桥接支架在开窗/分支腔内主动脉修复中显示初步良好结果,但需进一步评估VBX的耐久性。

研究设计与样本

  • 回顾性分析前瞻性收集的数据,纳入50例接受开窗或分支腔内移植物治疗复杂主动脉疾病并至少植入一枚VBX桥接支架且有6个月随访的患者。

主要发现

  • 共植入145枚VBX支架,技术成功率为98.6%。
  • 围术期及动脉瘤相关死亡率为0%,6个月全因死亡率为2%。
  • 发生6例器械相关再干预,原因包括4例IC型内漏、1例桥接支架远端靶血管狭窄和1例左肾动脉支架闭塞。

关键数值与推荐

  • 技术成功定义为桥接支架置于 desired position 且最终造影无内漏,本研究为98.6%。
  • 围术期及动脉瘤相关死亡率为0%,6个月全因死亡率为2%。

临床怎么用

  • 在F/BEVAR中可考虑使用VBX等桥接支架,但需注意IC型内漏、远端狭窄和支架闭塞等器械相关并发症。

局限性

  • 回顾性研究,样本量有限,随访仅6个月,VBX耐久性需进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Until today, no dedicated bridging stent graft (BSG) has been available for use in fenestrated and branched endovascular aneurysm repair (F/BEVAR). The purpose of this study was to evaluate the clinical performance of the well-known Advanta/iCast V12 (Getinge Maquet, Rastatt, Germany) and the new Viabahn VBX (W. L. Gore & Associates, Flagstaff, Ariz) balloon-expandable stent graft in F/BEVAR. METHODS: Retrospective analysis of prospectively collected data was performed. Inclusion criteria were treatment with fenestrated or branched endografts for complex aortic diseases, implantation of at least one VBX stent graft as a BSG in one of the target vessels, and clinical or radiologic follow-up of 6 months. The primary end point of the study was technical success of all BSGs, defined as placement of the BSG in the desired position with absence of endoleak on final angiography. Secondary end points were freedom from perioperative major adverse events and freedom from reinterventions and mortality at 6 months. Procedural and postoperative data were analyzed. RESULTS: Between December 2017 and July 2018, there were 50 patients (40 male; mean age, 71 years) included. A total of 145 VBX stent grafts were implanted, followed by 57 Advanta V12, 29 Viabahn, and 28 bare-metal stents. There were 126 branches (celiac trunk, 27; superior mesenteric artery, 25; renal arteries, 74) sealed exclusively with VBX. Technical success rate was 98.6%. There were six device-related reinterventions due to type IC endoleaks (n = 4), target vessel stenosis distal to the BSG, and stent graft occlusion in a left renal artery in one case. The perioperative and aneurysm-related mortality was 0%; the 6-month all-cause mortality was 2%. CONCLUSIONS: The used BSGs demonstrated promising preliminary results in F/BEVAR. Further evaluation is mandatory to determine durability of the VBX.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Torsello GF, Beropoulis E, Munaò R, et al. Outcomes of bridging stent grafts in fenestrated and branched endovascular aortic repair. J Vasc Surg. 2020. PMID: 31964573. doi:10.1016/j.jvs.2019.10.089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。